Inhalation CDMO Bespak announced that it has completed an independently verified life cycle assessment to evaluate environmental impacts associated with materials and manufacturing of its BK357 metered dose inhaler valve. The company said that the assessment is part of its sustainability effort, which also has included the addition of manufacturing capability for MDIs using LGWP propellants. Among other benefits, the report “provides clear direction for future carbon reduction initiatives at Bespak, including emission-saving opportunities in the material and energy stages of the product life cycle,” the company said.
According to Bespak’s web site, the BK357 valve platform “is used in more pMDI products, in more markets, than any other valve.” The site notes that the valve is compatible with LGWP propellants, including both HFO-1234ze and HFA-152a.
Bespak CEO Chris Hirst commented, “The completion of the LCA for our widely used and trusted BK357 pMDI valve demonstrates Bespak’s active commitment to championing sustainability in the supply chain for the benefit of customers, patients and the planet. We are excited to be actively researching solutions for carbon reduction beyond the propellant switch, and are proud to provide credible, independently verified data to back up our environmental claims.”
Bespak Head of ESG Benedicta Bakpa said, “This important milestone signifies our ongoing commitment to transparency and accountability in driving sustainable operations. As part of our overarching sustainability initiatives, we continue to identify opportunities to reduce our carbon footprint and work towards our near- and long-term net zero targets.”
Read the Bespak press release
